We serve Methyl 1H-Pyrrole-2-Carboxylate CAS:1193-62-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name: Methyl 1H-Pyrrole-2-Carboxylate
CAS.NO:1193-62-0
Molecular Formula:C6H7NO2
Molecular Weight:125.12500
Synonyms:
Methyl Pyrrole-2-carboxylate
Methyl 2-pyrrolecarboxylate
Pyrrole-2-carboxylic Acid Methyl Ester
Methyl 1H-pyrrole-2-carboxylate
Physical and Chemical Properties:
Density: 1.184g / cm3
Boiling point: 230.3ºC at 760mmHg
Melting point: 74-78ºC
Flash point: 93.1ºC
Refractive index: 1.526
Specification:
Appearance:White powder
Purity:≥99.0%
Moisture Content: 0.25%
Impurity: 0.3%
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application:An important raw material and intermediate used in Organic Synthesis,Pharmaceuticals.
Contact us for information like Methyl 1H-Pyrrole-2-Carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Methyl 1H-pyrrole-2-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Methyl 1H-Pyrrole-2-Carboxylate Use and application,Methyl 1H-Pyrrole-2-Carboxylate technical grade,usp/ep/jp grade.
Related News: “Our priority is not only to protect and inform the residents of Boston but also to help this man continue to recover.3-Pyridylacetic Acid Hydrochloride manufacturer “Our priority is not only to protect and inform the residents of Boston but also to help this man continue to recover.2-Isopropoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane supplier China has granted conditional approval to its first self-developed treatment for Alzheimer’s disease, a move that may point to revived opportunities in a therapeutic area where drugmakers have burned billions of dollars without yielding a validated new drug.1-bromo-9-fluorononane vendor However, in the long run, as the bulk API market continues to fall, more and more companies will transition to specialty API companies, and competition will intensify in the future.However, in the long run, as the bulk API market continues to fall, more and more companies will transition to specialty API companies, and competition will intensify in the future.
